For decades, scientists pursued the p38a protein as a key to treating cancer, inflammation, and neurodegeneration — yet every promising drug fell short. A team at IRB Barcelona has now revealed why: the protein quietly inhabits a second, oxidized form, sealed shut by a disulfide bridge, that no existing database had ever recorded. Because researchers were always studying p38a under conditions that erased this hidden state, they were designing drugs against a target that, in living cells, sometimes does not exist as they imagined it. The incomplete map, not the destination, was the problem all
News-Medical.net
· Dec 19, 2023
· health
· 2 min de leitura
High
Apuração: Verificado
Scientists discover hidden inactive form of p38a protein, reshaping drug design strategy
◉
Health & Medicine
8098 artigos relacionados
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 100% correspondência
Blood test could predict Covid-19 mortality risk, study finds
BreakingNews.ie · 99% correspondência
Hadassah performs world's first alpha radiation treatment for recurren…
jpost.com · 99% correspondência
Dr. Reddy's Wins Semaglutide Approval as Novo Nordisk Patent Challenge…
NDTV Profit · 99% correspondência
EU safety committee reviews reports of menstrual changes after mRNA CO…
CNBC · 99% correspondência
Cobertura Relacionada
The Guardian · Aug 20
Hundreds of thousands await GCSE results as gender gap narrows to 10-year low
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Biomedical discovery of p38a protein's oxidized form has no direct geopolitical implications; this is a scientific advancement in drug design methodology.
Escalation Risk
low
Confidence
HIGH
No geopolitical power dynamics affected. This is fundamental biomedical research with potential future pharmaceutical applications.
Lente Econômica
📈
Discovery of inactive p38a protein form could redirect pharmaceutical R&D toward cancer/inflammation treatments, potentially unlocking a multi-billion dollar market segment after decades of failed drug development attempts.
Market Signal
bullish
Confidence
MED
Pharmaceutical and biotechnology
Medical devices and diagnostics
Healthcare and hospital services
Contract research organizations (CROs)
Patients with cancer, chronic inflammation, and neurodegenerative diseases may eventually benefit from more effective treatments; however, drug development timelines are lengthy (10+ years), so near-term consumer impact is minimal.
Regulatory agencies (FDA, EMA) may need to update drug approval frameworks for p38a inhibitors based on this new protein conformation understanding; increased R&D funding for protein structure research may be justified through health policy initiatives.